Results 1,561-1,580 of 12,424 for speaker:Louise O'Reilly
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: There is a large number of questions that the witnesses have to get through, and we will make sure that they are answered. I am conscious that there is another group of three, and one more Deputy indicating. We will go back to the questions. I ask the witnesses to focus on very specific answers.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I ask the Deputy to hold his questions until we have a rota in operation.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I do not believe that there is anything in legislation that precludes Mr. Hennessy from answering the specific question that was asked.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: A specific drug was referred to, so, verbal gymnastics aside, I do not know how Mr. Hennessy is going to be able to answer the question without addressing the drug. It was Deputy Kelly's question and related to a specific drug.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: The answer to that question is that this drug is cost effective, then.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I was surmising that part of the answer to the question is that the drug is cost effective. We can tick that box, that it is cost effective.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: We are going down the road of being very specific about one drug in this regard.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: Will Professor Barry respond to that? Then we can move on to getting answers to the other questions that were asked.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I am conscious that questions from Deputy Brassil and Senator Swanick have not been answered yet. The witnesses might address those, please.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: Mr. Hennessy was asked for a date. He said that the process was in the final stages. What does that mean?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I am in the final stages of renovating a house, and my view on how long that will be is very different from what the people who are building it believe it will be. How long is a piece of string? If the process is in the final stages, are we talking days, weeks or months and will Mr. Hennessy give us a date?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I thank Mr. Hennessy.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: Deputy O'Connell will ask the quickest question in the world. Two other members have indicated.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: We can revert to that.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I thank the Deputy, who said that she would be brief. Senator Mullen asked a question, so the witnesses might address it. Three more members have indicated and will be taken next. The witnesses might keep their answers brief, but specific.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I must remind Senator Mullen that I am conscious there are people-----
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: Can I ask the witnesses to keep their responses as brief as they can because I am conscious that there are very patient committee members also waiting to come in?
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I thank Senator Dolan and Deputies Murphy and Durkan for their patience.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I invite Deputy Durkan, the master of brevity.
- Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)
Louise O'Reilly: I have no doubt.